{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T09:10:03Z","timestamp":1759569003512,"version":"build-2065373602"},"reference-count":45,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2012,7,1]],"date-time":"2012-07-01T00:00:00Z","timestamp":1341100800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,7,1]],"date-time":"2012-07-01T00:00:00Z","timestamp":1341100800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,6,8]],"date-time":"2022-06-08T00:00:00Z","timestamp":1654646400000},"content-version":"vor","delay-in-days":3629,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"name":"European Regional Development","award":["IGA MZ CR NS 10439-3\/2009, MPO FR-TI2\/254 and MSMT MSM0021622430"],"award-info":[{"award-number":["IGA MZ CR NS 10439-3\/2009, MPO FR-TI2\/254 and MSMT MSM0021622430"]}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","exphem.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Hematology"],"published-print":{"date-parts":[[2012,7]]},"DOI":"10.1016\/j.exphem.2012.02.005","type":"journal-article","created":{"date-parts":[[2012,2,27]],"date-time":"2012-02-27T12:13:54Z","timestamp":1330344834000},"page":"528-539.e4","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["A real-time (PCR) for a real life\u2026? Quantitative evaluation of BCL2\/IGH in follicular lymphoma and its implications for clinical practice"],"prefix":"10.1016","volume":"40","author":[{"given":"Andrea","family":"Janikova","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Mareckova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dana","family":"Dvorakova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zbynek","family":"Bortlicek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Boris","family":"Tichy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Milan","family":"Navratil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zdenek","family":"Kral","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarka","family":"Pospisilova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiri","family":"Mayer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.exphem.2012.02.005_bib1","doi-asserted-by":"crossref","first-page":"4537","DOI":"10.1200\/JCO.2008.16.1398","article-title":"Follicular Lymphoma, survival, and rituximab: is it time to declare victory?","volume":"26","author":"Horning","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.exphem.2012.02.005_bib2","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1200\/JCO.2005.03.3696","article-title":"Improvement of overall and failure-free survival in stage IV follicular lymphoma: 25 years of treatment experience at The University of Texas M.D.Anderson Cancer Center","volume":"24","author":"Liu","year":"2006","journal-title":"J Clin Oncol"},{"issue":"suppl","key":"10.1016\/j.exphem.2012.02.005_bib3","first-page":"110","article-title":"Survival in follicular lymphoma: The Stanford experience, 1960\u22122003","author":"Tan","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2012.02.005_bib4","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.3109\/10428191003743460","article-title":"Patterns of survival of follicular lymphomas at a single institution through three decades","volume":"51","author":"Conconi","year":"2010","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.exphem.2012.02.005_bib5","doi-asserted-by":"crossref","first-page":"4830","DOI":"10.1200\/JCO.2005.03.911","article-title":"Improved survival for patients with follicular lymphoma","volume":"23","author":"Lister","year":"2005","journal-title":"J\u00a0Clin Oncol"},{"issue":"22","key":"10.1016\/j.exphem.2012.02.005_bib6","doi-asserted-by":"crossref","first-page":"5019","DOI":"10.1200\/JCO.2005.04.503","article-title":"Improved survival of follicular lymphoma patients in the United States","volume":"23","author":"Swenson","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.exphem.2012.02.005_bib7","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1182\/blood-2010-03-272278","article-title":"Genomic alterations reveal potential for higher grade transformation in follicular lymphoma and confirm parallel evolution of tumor cell clones","volume":"116","author":"Eide","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2012.02.005_bib8","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1080\/10428190902927005","article-title":"The persistence of t(14; 18)- bearing cells in lymph nodes of patients with follicular lymphoma in complete remission: the evidence for \u201ca lymphoma stem cell\u201d","volume":"50","author":"Janikova","year":"2009","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.exphem.2012.02.005_bib9","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1111\/j.1365-2141.1995.tb05359.x","article-title":"New type of t(14;18) in a non-Hodgkin's lymphoma provides insight in molecular events in early B-cell differentiation","volume":"91","author":"Meijerink","year":"1995","journal-title":"Br J Heamatol"},{"key":"10.1016\/j.exphem.2012.02.005_bib10","doi-asserted-by":"crossref","first-page":"3275","DOI":"10.1182\/blood.V78.12.3275.3275","article-title":"All advanced stage non-Hodgkin\u2019s lymphomas with a polymerase chain reaction amplifiable breakpoint of bcl-2 have residual cells containing the bcl-2 rearrangement at evaluation and after treatment","volume":"78","author":"Gribben","year":"1991","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2012.02.005_bib11","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1200\/JCO.1993.11.9.1668","article-title":"Persistence of circulating t(14;18)-positive cells in long-term remission after radiation therapy for localized-stage follicular lymphoma","volume":"11","author":"Finke","year":"1993","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.exphem.2012.02.005_bib12","doi-asserted-by":"crossref","first-page":"3325","DOI":"10.1182\/blood.V94.10.3325.422k13_3325_3333","article-title":"Long-term follow-up of autologous bone marrow transplantation in patients with relapsed follicular lymphoma","volume":"94","author":"Freedman","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2012.02.005_bib13","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1111\/j.1365-2141.2008.07101.x","article-title":"Rapid and sustained clearance of circulating lymphoma cells after chemotherapy plus rituximab: clinical significance of quantitative t(14;18) PCR monitoring in advanced stage follicular lymphoma patients","volume":"141","author":"Hirt","year":"2008","journal-title":"Br J Haematol"},{"key":"10.1016\/j.exphem.2012.02.005_bib14","doi-asserted-by":"crossref","first-page":"2955","DOI":"10.1182\/blood.V91.8.2955.2955_2955_2960","article-title":"The clinical significance of molecular response in indolent follicular lymphomas","volume":"91","author":"Lopez-Guillermo","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2012.02.005_bib15","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1080\/1042819021000050052","article-title":"Incidence and clinical significance of Bcl-2\/IgH rearrangements in follicular lymphoma","volume":"44","author":"Montoto","year":"2003","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.exphem.2012.02.005_bib16","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1200\/JCO.1994.12.8.1541","article-title":"Clinical significance of t(14;18)-positive cells in the circulation of patients with stage III of IV follicular non-Hodgkin\u2019s lymphoma during first remission","volume":"12","author":"Lambrechts","year":"1994","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.exphem.2012.02.005_bib17","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1200\/JCO.1994.12.4.798","article-title":"Detection of cells bearing the t(14; 18) translocation following myeloablative treatment and autologous bone marrow transplantation for follicular lymphoma","volume":"12","author":"Johnson","year":"1994","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.exphem.2012.02.005_bib18","doi-asserted-by":"crossref","first-page":"2246","DOI":"10.1200\/JCO.2009.25.0852","article-title":"Bcl-2\/IgH polymerase chain reaction status at the end of induction treatment is not predictive for progrression-free survival in relapsed\/resistant follicular lymphoma: results of a prospective randomized EORTC 20981 phase III intergroup study","volume":"28","author":"Van Oers","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.exphem.2012.02.005_bib19","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/sj.bmt.1704102","article-title":"Quantitative molecular evaluation in autotransplant programs for follicular lymphoma: efficacy of in\u00a0vivo purging by rituximab","volume":"32","author":"Galimberti","year":"2003","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.exphem.2012.02.005_bib20","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1038\/sj.bmt.1702147","article-title":"Quantitative detection of t(14;18)-positive cells in patiens with follicular lymphoma before and after autologous bone marrow transplantation","volume":"25","author":"Hirt","year":"2000","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.exphem.2012.02.005_bib21","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S0301-472X(00)00651-2","article-title":"A validated real-time approach show a correlation between tumor burden and successful ex\u00a0vivo purging in follicular lymphoma patients","volume":"29","author":"Ladetto","year":"2001","journal-title":"Exp Haematol"},{"key":"10.1016\/j.exphem.2012.02.005_bib22","doi-asserted-by":"crossref","first-page":"3428","DOI":"10.1182\/blood-2004-06-2490","article-title":"Quantitative PCR of bone marrow BCL2\/IgH+ cells at diagnosis predicts treatment response and long-term outcome in follicular non-Hodgkin lymphoma","volume":"105","author":"Rambaldi","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2012.02.005_bib23","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1182\/blood.V114.22.441.441","article-title":"Quantitative real-time PCR in peripheral blood t(14;18) cells predicts treatment response and long-term outcome in patients with follicular lymphoma","volume":"114","author":"Zohren","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2012.02.005_bib24","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1182\/blood.V99.3.856","article-title":"Monitoring of minimal residual disease after CHOP and rituximab in previously untreated patients with follicular lymphoma","volume":"99","author":"Rambaldi","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2012.02.005_bib25","doi-asserted-by":"crossref","first-page":"2654","DOI":"10.1200\/JCO.2004.07.170","article-title":"Fludarabine plus mitoxantrone with and without rituximab versus CHOP with and without rituximab as front-line treatment for patients with follicular lymphoma","volume":"22","author":"Zinzani","year":"2004","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.exphem.2012.02.005_bib26","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1182\/blood.V98.4.940","article-title":"Lack of correlation between numbers of circulating t(14;18)-positive cells and response to first-line treatment in follicular lymphoma","volume":"98","author":"Mandigers","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2012.02.005_bib27","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1007\/s00277-003-0762-6","article-title":"Dynamics of circulating t(14;18)-positive cells during first-line and subsequent lines of treatment in follicular lymphoma","volume":"82","author":"Mandigers","year":"2003","journal-title":"Ann Hematol"},{"key":"10.1016\/j.exphem.2012.02.005_bib28","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1046\/j.1365-2141.2002.03623.x","article-title":"JH probe real-time quantitative polymerace Chin reaction assay for Bcl-2\/IgH rearrangements","volume":"118","author":"Jenner","year":"2002","journal-title":"Br J Haematol"},{"key":"10.1016\/j.exphem.2012.02.005_bib29","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1200\/JCO.1999.17.4.1244","article-title":"Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas","volume":"17","author":"Cheson","year":"1999","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.exphem.2012.02.005_bib30","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1200\/JCO.2006.09.2403","article-title":"Revised response criteria for malignant lymphoma","volume":"25","author":"Cheson","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.exphem.2012.02.005_bib31","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.2144\/98256cr05","article-title":"Quantitative detection of t(14;18)-positive cells by real-time quantitative PCR using fluorogenic probes","volume":"25","author":"D\u00f6lken","year":"1998","journal-title":"Biotechniques"},{"key":"10.1016\/j.exphem.2012.02.005_bib32","doi-asserted-by":"crossref","first-page":"3800","DOI":"10.1182\/blood.V83.12.3800.3800","article-title":"Detection of residual lymphoma cells by polymerase chain reaction in peripheral blood is significantly less predictive for relapse than detection in bone marrow","volume":"83","author":"Gribben","year":"1994","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2012.02.005_bib33","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1038\/sj.leu.2403202","article-title":"Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: report of the BIOMED-2 concerted action BMH4-CT98-3936","volume":"17","author":"van Dongen","year":"2003","journal-title":"Leukaemia"},{"key":"10.1016\/j.exphem.2012.02.005_bib34","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1093\/clinchem\/47.4.667","article-title":"Determination of RhD zygosity: comparison of a double amplification refractory mutation system approach and a multiplex real-time quantitative PCR approach","volume":"47","author":"Chiu","year":"2001","journal-title":"Clin Chem."},{"key":"10.1016\/j.exphem.2012.02.005_bib35","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1053\/beha.2002.0216","article-title":"Molecular remission and non-Hodgkin's lymphoma","volume":"15","author":"Darby","year":"2002","journal-title":"Best Pract Res Clin Haematol"},{"key":"10.1016\/j.exphem.2012.02.005_bib36","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/S0002-9440(10)64905-X","article-title":"High frequency of t(14;18)-translocation breakpoints outside of major breakpoint and minor cluster regions in follicular lymphomas","volume":"160","author":"Albinger-Hegyi","year":"2002","journal-title":"Am J Pathol"},{"key":"10.1016\/j.exphem.2012.02.005_bib37","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.jmoldx.2010.11.019","article-title":"Demonstration of array-based analysis for highly multiplexed PCR assays application to detection of IGH\/BCL2 translocations in FFPE follicular lymphoma specimens","volume":"13","author":"Spence","year":"2011","journal-title":"J Mol Diagn"},{"key":"10.1016\/j.exphem.2012.02.005_bib38","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1097\/PDM.0b013e31814be9e0","article-title":"Combined molecular diagnosis of B-cell lymphomas with t(11;14)(q13;q32) or t(14;18) (q32;q21) using multiplex- and long distance inverse-polymerase chain reaction","volume":"17","author":"Vieira","year":"2008","journal-title":"Diagn Mol Pathol"},{"key":"10.1016\/j.exphem.2012.02.005_bib39","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1182\/blood-2009-01-198580","article-title":"Follicular lymphomas with and without translocation t(14;18) differ in gene expression profiles and genetic alterations","volume":"114","author":"Leich","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2012.02.005_bib40","doi-asserted-by":"crossref","first-page":"293","DOI":"10.3816\/CLM.2001.n.004","article-title":"Weekly x 4 induction therapy with the anti-CD20 antibody rituximab: effect on circulating t(14;18)+ follicular lymphoma cells","volume":"1","author":"Pichert","year":"2001","journal-title":"Clin Lymphoma"},{"key":"10.1016\/j.exphem.2012.02.005_bib41","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1046\/j.1365-2141.2002.03641.x","article-title":"The relative role of peripheral blood and bone marrow for monitoring molecular evidence of disease in follicular lymphoma by quantitative real-time polymerase chain reaction","volume":"118","author":"Summers","year":"2002","journal-title":"Br J Haematol"},{"key":"10.1016\/j.exphem.2012.02.005_bib42","doi-asserted-by":"crossref","first-page":"2192","DOI":"10.1182\/blood.V99.6.2192","article-title":"Tumor cell dissemination in follicular lymphoma","volume":"99","author":"Oeschger","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2012.02.005_bib43","doi-asserted-by":"crossref","first-page":"1900","DOI":"10.1182\/blood.V95.6.1900","article-title":"Cell adhesion receptors in lymphoma dissemination (review)","volume":"95","author":"Drillenburg","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2012.02.005_bib44","doi-asserted-by":"crossref","first-page":"4555","DOI":"10.1200\/JCO.2008.21.3991","article-title":"Follicular lymphoma international prognostic index 2: a new prognostic index for follicular lymphoma developed by the International Follicular Lymphoma Prognostic Factor Project","volume":"27","author":"Federico","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.exphem.2012.02.005_bib45","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1016\/j.leukres.2006.01.014","article-title":"One single dose of rituximab added to a standard regimen of CHOP in primary treatment of follicular lymphoma appears to result in a high clearance rate from circulating bcl-2\/IgH positive cells: is the end of molecular monitoring near?","volume":"30","author":"Schmitt","year":"2006","journal-title":"Leuk Res"}],"container-title":["Experimental Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301472X12000847?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301472X12000847?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T08:30:03Z","timestamp":1759566603000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0301472X12000847"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,7]]},"references-count":45,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2012,7]]}},"alternative-id":["S0301472X12000847"],"URL":"https:\/\/doi.org\/10.1016\/j.exphem.2012.02.005","relation":{},"ISSN":["0301-472X"],"issn-type":[{"type":"print","value":"0301-472X"}],"subject":[],"published":{"date-parts":[[2012,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A real-time (PCR) for a real life\u2026? Quantitative evaluation of BCL2\/IGH in follicular lymphoma and its implications for clinical practice","name":"articletitle","label":"Article Title"},{"value":"Experimental Hematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.exphem.2012.02.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 ISEH - Society for Hematology and Stem Cells. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}